BOTULINUM TOXIN THERAPY IN THE TREATMENT OF SPASTIC TYPE OF CEREBRAL PALSY IN CHILDREN: SIDE EFFECTS AND THEIR PREVENTION
Keywords:
cerebral palsy in children, spasticity, botulinum toxin, botulinum therapy, side effects, prevention.Abstract
Spastic type of cerebral palsy (CP) in children results from congenital or early childhood injury to the central nervous system. Spasticity is the leading clinical symptom in this condition. Currently, botulinum toxin (BTX) is widely used in the treatment of spastic CP. This article analyzes the clinical efficacy of botulinum toxin therapy, possible side effects, and methods for their prevention.
Downloads
References
Heinen F, et al. "The updated European Consensus 2021 on Botulinum toxin for children with cerebral palsy."
Fehlings D, Novak I, et al. "Botulinum toxin in the management of children with cerebral palsy: an evidence-based review."
Delgado MR, et al. "Practice parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy."
Graham HK, et al. "A systematic review of botulinum toxin for spasticity in children with cerebral palsy."
Boyd RN, et al. "Cerebral palsy: clinical and research perspectives."
Tashkent – 2025
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in the Journal of Applied Science and Social Science (JASSS) is protected by copyright. Authors retain the copyright to their work, and grant JASSS the right to publish the work under a Creative Commons Attribution License (CC BY). This license allows others to distribute, remix, adapt, and build upon the work, even commercially, as long as they credit the author(s) for the original creation.